Groups of scientists all over the world have had their hands on deck seeking the 'magical' vaccine that could see to the end of the COVID-19 pandemic.
Now, there's been a rather partial breakthrough as a Monash University-led study has discovered an antiparasite drug, Ivermectin, that could stop the SARS-CoV-2 virus cells within the surprisingly short space of 48 hrs.
According to the Monash Biomedicine Discovery Institute's Dr Kylie Wagstaff, ''We found that even a single dose could essentially remove all viral RNA (effectively removed all genetic material of the virus) by 48 hours and that even at 24 hours there was a really significant reduction in it".
However, the team is yet to make human trials of the drug. According to them, it would start in at least in a month's time.
So, once it's found that the drug is friendly with the human biological systems, thus, suitable for human consumption, then, it's most likely the very end of the coronavirus pandemic.
Share your thoughts.
Content created and supplied by: Declandozie (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More